Observe Medical ASA Statistics
Total Valuation
OSL:OBSRV has a market cap or net worth of NOK 75.10 million. The enterprise value is 156.49 million.
Market Cap | 75.10M |
Enterprise Value | 156.49M |
Important Dates
The next estimated earnings date is Friday, August 29, 2025.
Earnings Date | Aug 29, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
OSL:OBSRV has 92.15 million shares outstanding. The number of shares has increased by 297.36% in one year.
Current Share Class | 92.15M |
Shares Outstanding | 92.15M |
Shares Change (YoY) | +297.36% |
Shares Change (QoQ) | +40.17% |
Owned by Insiders (%) | 2.39% |
Owned by Institutions (%) | 0.38% |
Float | 76.85M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 4.06 |
PB Ratio | 3.55 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -2.66 |
EV / Sales | 8.47 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -5.35 |
Financial Position
The company has a current ratio of 0.20, with a Debt / Equity ratio of 3.94.
Current Ratio | 0.20 |
Quick Ratio | 0.11 |
Debt / Equity | 3.94 |
Debt / EBITDA | n/a |
Debt / FCF | -2.85 |
Interest Coverage | -4.65 |
Financial Efficiency
Return on equity (ROE) is -189.43% and return on invested capital (ROIC) is -27.55%.
Return on Equity (ROE) | -189.43% |
Return on Assets (ROA) | -17.55% |
Return on Invested Capital (ROIC) | -27.55% |
Return on Capital Employed (ROCE) | -53.64% |
Revenue Per Employee | 3.70M |
Profits Per Employee | -11.75M |
Employee Count | 5 |
Asset Turnover | 0.12 |
Inventory Turnover | 2.52 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -87.26% in the last 52 weeks. The beta is -0.02, so OSL:OBSRV's price volatility has been lower than the market average.
Beta (5Y) | -0.02 |
52-Week Price Change | -87.26% |
50-Day Moving Average | 1.17 |
200-Day Moving Average | 3.91 |
Relative Strength Index (RSI) | 59.87 |
Average Volume (20 Days) | 153,703 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, OSL:OBSRV had revenue of NOK 18.48 million and -58.73 million in losses. Loss per share was -3.90.
Revenue | 18.48M |
Gross Profit | 3.07M |
Operating Income | -44.40M |
Pretax Income | -58.73M |
Net Income | -58.73M |
EBITDA | -32.56M |
EBIT | -44.40M |
Loss Per Share | -3.90 |
Balance Sheet
The company has 1.98 million in cash and 83.37 million in debt, giving a net cash position of -81.39 million or -0.88 per share.
Cash & Cash Equivalents | 1.98M |
Total Debt | 83.37M |
Net Cash | -81.39M |
Net Cash Per Share | -0.88 |
Equity (Book Value) | 21.14M |
Book Value Per Share | 1.10 |
Working Capital | -48.14M |
Cash Flow
In the last 12 months, operating cash flow was -27.43 million and capital expenditures -1.84 million, giving a free cash flow of -29.27 million.
Operating Cash Flow | -27.43M |
Capital Expenditures | -1.84M |
Free Cash Flow | -29.27M |
FCF Per Share | -0.32 |
Margins
Gross Margin | 16.63% |
Operating Margin | -240.22% |
Pretax Margin | -317.74% |
Profit Margin | n/a |
EBITDA Margin | -176.18% |
EBIT Margin | -240.22% |
FCF Margin | n/a |
Dividends & Yields
OSL:OBSRV does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -297.36% |
Shareholder Yield | n/a |
Earnings Yield | -78.20% |
FCF Yield | -38.98% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on January 14, 2025. It was a reverse split with a ratio of 0.0666666667.
Last Split Date | Jan 14, 2025 |
Split Type | Reverse |
Split Ratio | 0.0666666667 |
Scores
OSL:OBSRV has an Altman Z-Score of -4.32 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -4.32 |
Piotroski F-Score | 1 |